Change in quality of life (EQ-5D) among type 2 diabetes mellitus patients inadequately controlled with metformin plus sulfonylurea and treated with dapagliflozin as triple therapy regimen for 24 weeks
Abstract
Authors
C. Sternhufvud K. Rohwedder J. Sugg S. Grandy